НовостиBenzingaHC Wainwright & Co. Reiterates Buy on Generate Biomedicines, Maintains $30 Price Target HC Wainwright & Co. Reiterates Buy on Generate Biomedicines, Maintains $30 Price Target Benzinga 2026.10.05 10:38 (GMT+0) Открыть на Benzinga Другие новости